January 14, 2023
3 min watch
Save
VIDEO: Orasis provides update on positive data for presbyopia drop
KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2023, Paul Smith of Orasis Pharmaceuticals discusses phase 3 data for the CSF-1 eye drop for presbyopia treatment following its new drug application submission to the FDA.
“We’re encouraged to report that CSF-1 does indeed hit its mark,” he said. “We are excited to be next in this new and emerging category.”
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Smith reports being the Chief Operating Officer of Orasis.
Read more about